Correlation Between Monte Rosa and Arvinas

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Arvinas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Arvinas into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Arvinas, you can compare the effects of market volatilities on Monte Rosa and Arvinas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Arvinas. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Arvinas.

Diversification Opportunities for Monte Rosa and Arvinas

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Monte and Arvinas is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Arvinas in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arvinas and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Arvinas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arvinas has no effect on the direction of Monte Rosa i.e., Monte Rosa and Arvinas go up and down completely randomly.

Pair Corralation between Monte Rosa and Arvinas

Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 1.01 times more return on investment than Arvinas. However, Monte Rosa is 1.01 times more volatile than Arvinas. It trades about 0.01 of its potential returns per unit of risk. Arvinas is currently generating about -0.04 per unit of risk. If you would invest  582.00  in Monte Rosa Therapeutics on November 29, 2024 and sell it today you would lose (4.00) from holding Monte Rosa Therapeutics or give up 0.69% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Monte Rosa Therapeutics  vs.  Arvinas

 Performance 
       Timeline  
Monte Rosa Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Monte Rosa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Arvinas 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Arvinas has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Monte Rosa and Arvinas Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monte Rosa and Arvinas

The main advantage of trading using opposite Monte Rosa and Arvinas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Arvinas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will offset losses from the drop in Arvinas' long position.
The idea behind Monte Rosa Therapeutics and Arvinas pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
FinTech Suite
Use AI to screen and filter profitable investment opportunities